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Abstract: Synthetic nonionic surfactant vesicles (niosomes)
are a colloidal system with closed bilayer structures, dis-
playing distinct advantages in stability and cost compared
with liposomes. In this article, polysorbate cationic nio-
somes (PCNs) were developed as gene carriers. The PCNs
comprised nonionic surfactants (i.e., polysorbates) and a
cationic cholesterol, and were synthesized using a film
hydration method. The niosomes thus prepared possessed a
regular morphology, and a particle size of 100  200 nm,
and a zeta potential of þ30  45 mV. The PCNs showed
great physical stability over the course of 4 weeks at room
temperature. The binding capacity of PCNs toward oligo-
deoxynucleotides (ODN) was assessed by a gel retardation
approach, which demonstrated that the ionic complexes
were formed when 6 charge ratio reached to 4 or greater.
Gene transfer study showed that the PCNs exhibited a high
efficiency in mediating cellular uptake and transferred DNA
expression. Based on these findings, PCNs may offer the
potential to function as an effective gene delivery system.
VC 2011 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 96A: 513–
519, 2011.
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INTRODUCTION
Synthetic nonionic surfactant vesicles (niosomes), the closed
bilayer vesicles resulting from self-assembly of nonionic
amphiphiles in aqueous media, bear similarity to liposomes
in structure.1 Like liposomes, they are also capable of
entrapping either hydrophilic drug in the interior aqueous
phase or hydrophobic drugs within their bilayer (Scheme 1).
The biopharmaceutical functions of niosomes are quite like
those of liposomes, such as prolonging circulation of
entrapped drugs and altering their organ distribution as well
as increasing metabolic stability.2 Indeed, niosomes have
been of great attraction due to their own intrinsic chemical
properties and therefore often serve as an alternative to
liposomes. At the same time, niosomes are recognized for
the superiority in cost effectiveness, chemical stability, and
storage when compared with their relevant counterparts.3
Niosomes have been widely employed in drug delivery
meant to improve therapeutic efficacy of drugs (e.g., chemo-
therapy drugs,2,4–6 peptides,7–9 and protein vaccines10,11),
and also been considered to be biodegradable, biocompati-
ble, and nonimmunogenic.12 Nevertheless, the literature on
the use of niosomes for gene delivery has a very limited
amount.
Among various nonionic surfactants, sorbitan mono-
esters (SpanV
R
)13–15 and polysorbates (TweenV
R
)16–19 are
commonly used as additives to formulate lipid-based gene
carriers. Compared with sorbitan monoesters, it is worth
noting that not only are polysorbates a critical class of
emulsifier and stabilizer in those reported formulations, but
also play an active role in biological integration with DNA,
thereby promoting gene expression.16,18 In this regard, we
hypothesized that polysorbate cationic niosomes (PCNs)
could function as a vector for therapeutic genes in terms of
the abovementioned unique properties of polysorbates. To
validate our speculation, PCNs, containing Tween 20, 40, 80,
or 85, were prepared by using cationic lipid (3-b-N-(N0,N0-
dimethylaminoethan)-carbamoyl]cholesterol, DC-Chol) as a
membrane-stabilized additive, via application of the film
hydration method accompanied with sonication. The cellular
uptake efficiency and gene transfer ability of these PCNs






20, 40, 80, 85) were
obtained from Shanghai Chemical Reagent Co. The DC-Chol
compound was synthesized according to the procedure
described by Gao and Huang.20 Cholesterol was obtained
from Sigma-Aldrich (St. Luise, USA). A model ODN with a
15-mer random sequence was synthesized by Sangon Bio-
engineering Technology Co. (Shaighai, China), and the 50 end
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was labeled with carboxyfluorescein. All other reagents
were of analytical grade supplied by Huadong Medical Co.
(Hangzhou, China).
The COS-7 cell line and pGFP-N1 were kindly provided
by Sir Run Run Shaw Hospital, Zhejiang University, and cells
were cultured with Dulbecco’s modification of Eagle’s
medium (Gibco) with 10% FBS (Hangzhou Sijiqing Bio-
engineering Material Co., China).
Preparation of PCNs
Niosomes were prepared by using the film hydration
method with sonication. In brief, the amphiphile mixture
composed of equal molar ratios of Tween and DC-Chol (50
lmol) was dissolved in chloroform in a pear-shaped flask,
and the organic solvent was dried under vacuum using a
rotary evaporator. The resultant lipid film was then
hydrated using 5 ml double distilled water, and the flask
was rotated in a water bath at 60C for 20 min. The
obtained PCN dispersions were then sonicated using a soni-
fier (200 w, 3 min) equipped with an ice-water bath. An
aseptic final product for cellular studies was obtained by
filtration through 0.2-lm filter membrane.
Transmission electron microscopy (TEM) study
The PCN suspension was added to a carbon-coated copper
grid and left for 1 min to allow adhesion between the
vesicles and the carbon substrate. Excess of the suspension
was then removed with a piece of filter paper. A drop of 2%
phosphotungstic acid solution was applied to the grid for
negative staining, and the sample was air-dried. The mor-
phology of PCNs was examined using a JEM-1200EX TEM
apparatus (JEOL, Japan).
Measurement of particle sizes and zeta potentials
Particle-size and zeta potential of the PCNs were deter-
mined by using laser diffraction spectrometry (Malvern
Zetasizer 3000HS, Malvern, U.K.).
Physical stability of niosomal vesicles
For the physical stability study, the PCN suspensions were
stored in glass vials at room temperature for four weeks.
Aliquots were sampled from each vial at week 0, 1, 2, and
4, for monitoring the particle size change.
Gel retardation assay
ODN/PCN complexes were prepared by simply mixing equal
volumes of the PCN and ODN solutions at the 6 charge ra-
tio of 0.5:1, 1:1, 2:1, or 4:1. Briefly, the ODN solution was
rapidly pipetted into the PCN suspension under thorough
mixing, and the mixture was then incubated for 10 min at
room temperature to allow the formation of PCN/ODN com-
plexes. The complexes were carefully added to an agarose
gel (0.8%) at a volume representing 2 lg of ODN per well,
along with varying amount of PCNs according the charge
ratio described above. Free ODN was used as the control.
Gel electrophoresis was carried out at a voltage of 60 V.
SCHEME 1. Self-assembling of niosomes. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Cellular uptake experiment
COS-7 cells were seeded in 24-well plates and cultured in
10% FBS/DMEM medium to 90% confluence at 37C in a
5% CO2 humidified incubator prior to the uptake experi-
ments. With the 6 charge ratio of 4:1, PCNs and 1 lg of flu-
orescein labeled ODN in equal volume were mixed and incu-
bated for 15 min to form the complexes. The complexes
were then added to cells right after replacing the culture
medium with FBS-free medium. Following incubation for 4
h, the culture medium was removed. The cells were then
washed twice with PBS, collected by trypsinization, centri-
fuged (1200  g, 3 min), and washed twice again with PBS.
The cells were then resuspended in PBS and analyzed by
flow cytometry (Beckman Coulter). The percentage of posi-
tive fluorescence cells (a) and mean of fluorescent intensity
(MFI) were determined. Cellular uptake efficiencies were
assessed by calculating the total fluorescent intensity (TFI)
according to the equation as follows:
TFI ¼ aMFI 104
Cellular gene transfection experiment
Plasmid DNA of pEGFP-N1 was used as the model gene. The
COS-7 cells were cultured to 80% confluence as described
above. The DNA/PCNs complexes were prepared by mixing
equal volumes of PCNs and DNA at a 6 charge ratio of 4:1,
followed by incubation of the mixture for 15 min. The cells
were exposed to the complexes at a DNA level of 2 lg per
well for 4 h in FBS-free medium, and were then further
incubated for 24 h in 10% FBS/DMEM medium. Cells were
then observed using an inverted fluorescent microscope
(Zeiss HBO100) to assess the gene transfection. Commercial-
ized DOPE/DC-Chol cationic liposomes were set up as a
positive control.
Statistical analysis
Each experiment was performed in triplicate, and data were
expressed as mean 6 SD. Statistical analyses were per-
formed using the Student’s t-test.
RESULTS
The typical TEM images of PCNs formulated by using Tween
85 and DC-Chol are shown in Figure 1. The niosomes dis-
played discrete spherical shapes with distinct boundaries.
The size ranged from 100 to 200 nm, in accordance with
results obtained from particle sizing by laser diffraction
spectrometry (Table I). The average diameters of PCNs con-
taining various Tween were slightly different, but all were
FIGURE 1. TEM images of Tween85 cationic niosomes.
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less than 200 nm. Cholesterol is the most commonly mem-
brane stabilizer, which is found both in living cells and syn-
thetic bilayer membranes (e.g., niosomes). The well-defined
vesicle shapes observed in the TEM images indicated that
the strategy of substituting cholesterol with DC-Chol to
achieve the bilayer membrane formation worked reasonably
well, presumably due to the same parent structure. Mean-
while, with the cationic component of DC-Chol, the zeta
potentials of all the niosomes were above þ30 mV; a
well-accepted electrostatic stabilization level.21 Such high
surface charges were expected to provide sufficient electro-
static repulsion between vesicles, thereby preventing aggre-
gation. This assumption was further confirmed by the
subsequent stability study.
It should be noted that particle size is not only a param-
eter for characterization of the colloidal drug delivery sys-
tems but also a stability response indicator in that aggrega-
tion and fusion of colloidal vesicles would normally lead to
increased particle size.21 The more the size increase is, the
less stable the niosomal system. In this regard, the stability
of PCNs was investigated by monitoring the change in parti-
cle size for a period of four weeks. Results showed that the
size of PCNs increased relatively insignificantly during the
four-week storage period (Fig. 2), indicating good physico-
chemical stability of these PCNs. As noted, the nano-scale
particle size and high absolute value of zeta potential are
two important parameters in stabilizing this colloidal sys-
tem. In addition, the hydrophilic polyoxyethylene chains of
Tween on the surface of the vesicle would cover it like an
umbrella, actively preventing it from fusion with other
vesicles.
The formation of the self-assemble complexes of ODN/
PCNs was examined using agarose gel electrophoresis. The
ODN-binding capacity of PCNs was depicted by a specific
charge ratio (þ/) at which ODN gel migration was
retarded. As shown in Figure 3, the migration band of ODN
gradually decreased along with the elevating charge of
PCNs. When the charge ratio (6) was 4 or greater, ODN
was completely retarded, indicating that a solid complex
was formed. The ODN, as low as 0.08 lg, was able to be
detected in this gel electrophoresis system. Thus, any invisi-
ble band of free ODN can be calculated as 1ess than 0.08
lg, that is, the retarded ODN greater than 1.92 lg (taken 2
lg of total ODN into account). This means that the binding
efficiency of ODN with PCNs is >96%. Such an ODN-binding
capacity (i.e., the charge ratio of 4:1) was used for the prep-
aration of ODN/PCN complexes.
The cellular uptake study showed that PCNs achieved a
varying degree of enhancement of cellular uptake compared
with the cationic liposomes (soybean phospholipids/DC-
Chol, 1:1, molar ratio) in the COS-7 cell line. The cellular
uptake efficiency of the control naked fluorescent ODN was
very low: at a background level. Significant elevations were
seen in Tween 85-, 80-, and 40-niosomes (p < 0.05)
(Fig. 4). This indicated that, besides DC-Chol, Tween also
acted importantly on mediating ODN cellular uptake. The
enhancement was in a pattern corresponding to the
decreasing hydrophilic/lipophilic balance (HLB) values of
these tested Tween surfactants. Since the highest cellular
uptake efficiency was seen in Tween-85 niosomes (p <
0.05), the plausibility of mediating gene transfection was
investigated by using the plasmid pEGFP-N, which encodes
a red-shifted variant of wild-type green fluorescent protein
(GFP). Adequate GFP expression was found under an
inverted fluorescent microscope, which displayed a level
TABLE I. Particle Size and Zeta Potential of Tween Cationic
Niosomes
Tw85-nio Tw80-nio Tw40-nio Tw20-nio
Size/nm 182.6 6 7.3 127.5 6 9.2 151.3 6 6.7 159.8 6 10.1
Zeta/mV 41 6 1 45 6 2 32 6 1 34 6 2
FIGURE 2. Particle size change during four-week storage. [Color
figure can be viewed in the online issue, which is available at
wileyonlinelibrary.com.]
FIGURE 3. Agarose gel electrophoresis of Tween 85 niosome/ODN.
lane, free OND; lane 2-5, Niosome/ODN with 6 ratio of 0.5:1, 1:1, 2:1,
and 4:1 respectively With 6 ratio of 2:1 (Lane 4), slightly strap of OND
was visible, while at lane 5 a complete retardation of ODN was per-
formed with 6 charge ratio of 4:1 or above.
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comparable to the control DOPE/DC-Chol liposomes (Fig. 5).
This revealed the high gene transfection capacity of Tween-
85 cationic niosomes.
DISCUSSION
Niosomes composed of Tween and membrane additives
(e.g., cholesterol,22 fatty alcohols23) have been investigated
for drug delivery. However, the preparation of PCN and its
application gene delivery have not been reported yet. A se-
ries of surfactants, including Tween 85, 80, 40, and 20,
were selected to formulate the cationic niosomes in this
study. Tween are one of the most commonly used nonionic
surfactants in pharmaceutical industry. An attractive prop-
erty in Tween structure is the hydrophilic polyoxyethylene
chains (Fig. 6), which have been demonstrated to possess a
functional interaction with DNA, and used as a gene transfer
helper. For example, Tween 80 was reported to have an
advantage in preventing the large formation of gene/lipid
complexes over other nonionic surfactants like Span, and
this activity may associate with its hydrophilic polyoxyethy-
lene head.16,18 Essentially, all Tween surfactants possess the
common hydrophilic polyoxyethylene head (i.e., 20 POE
groups and a sorbitan ring), but only varying in their hydro-
phobic tails, and thus different kinds of Tween compounds
presumably possess a function in facilitating gene transfer.
Our results showed that there were enhancements in
efficiency of ODN cellular uptake mediated by all PCNs,
compared with the cationic liposomes.
It was interesting that cellular uptake efficiency
increased in correspondence with the lower HLB value of
Tween. The Tween 85 cationic niosomes, with a significant
enhancement, displayed the highest efficiency among all the
tested formulations. Although the precise mechanism is yet
not well understood, some factors such as hydrophobicity,
FIGURE 4. The cellular uptake of OND mediated by Tween cationic
niosomes. Each experiment was performed in triplicate and the val-
ues were expressed as mean 6 S.D. Statistical analyses were per-
formed using Student’s t-test. Tw85 niosomes was with the highest
efficiency among the Tween cationic niosomes. The result showed
that higher hydrophilic the Tween was, the less cellular uptake
efficient. Note: (1) vs. other three groups, p < 0.05; (2) vs. CL groups,
p < 0.05.
FIGURE 5. Green Fluorescent Protein expression in COS-7 cell line
with Tw85 cationic niosomes (A) and DOPE/DC-Chol liposomes (B)
mediated pEGFP-N1 gene transfection. [Color figure can be viewed in
the online issue, which is available at wileyonlinelibrary.com.]
FIGURE 6. Chemical structure of a series of Tween.
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electrostatic interaction and amphiphilic structure are
believed to be involved in the process of cellular uptake
mediated by non-virus vectors.24 Among these four surfac-
tant compounds, Tween 85 displays the unique structure in
which there are three hydrophobic chains with 18 carbon
atoms, with the lowest HLB of 11, and it thereby acquires
some organic solubility. Solubilization and perturbation of
membrane lipid layers by nonionic surfactants have been
revealed to be closely related to their hydrophobicity, indi-
cated by HLB values; for example, increasing membrane flu-
idity was caused by Tween surfactants in an order of Tween
85 > Tween 80 > Tween 60 > Tween 40 > Tween 20.25
Therefore, the longer hydrophobic chains of Tween 85 may
favor cellular uptake via a stronger interaction with mem-
brane lipids.
Endosome escape is known as one of the crucial bar-
riers for intracellular gene delivery. Tween was believed to
bear a fusogenic property similar to DOPE, which is one of
the most commonly used helper-lipids in facilitating the
DNA-escape from the endosome to the cytosol by promoting
a lamellar-to-inverted hexagonal phase transition of cationic
liposome-DNA complexes16,26 A Tween surfactant with high
HLB can be solubilized in water by hydration of the poly-
oxyethylene groups. As for Tween 85, however, bulky hydro-
phobic chain regions make the polyoxyethylene groups less
accessible and thereby less soluble. A plausible explanation
for the fusogenic function of Tween 85 in DNA transfer is
that Tween 85 tends toward a transition to reverted phase
in a lipophilic environment (e.g., inside the membrane) due
to its hydrophobic bulk. Additionally, the destabilization
membrane effect of Tween 85 could also play a key role on
gene intracellular transport, for example, disturbing endo-
some membrane.
Cholesterol is the most general membrane additive in
niosomal systems, in which cholesterol plays an important
role in abolishing the gel-to-liquid phase transition and
enhancing the physico-chemical colloidal stability, thereby
facilitating the formation of bilayer vesicles. In our previous
studies we have demonstrated the success of substituting
cholesterol with DC-Chol for preparing cationic niosomes,
and potential of utilizing sorbitan monoester (Span) cationic
niosomes as gene carriers.27,28 This cationic cholesterol de-
rivative, DC-Chol, has also been shown to be capable of act-
ing as a membrane stabilizer in the presented PCN systems.
Given the cationic property of DC-Chol, its function in the
PCNs is not only to condense the delivered gene, but also to
stabilize the niosomal system because of the creation of an
electrostatic repellent effect by addition of charged additives
to the bilayer.3
Cationic niosomes are biodegradable and biocompatible
drug carriers. In our previous study, Span/Dc-Chol cationic
niosomes displayed low cytotoxicity, remaining viability of
above 80% on COS-7 cells with a concentration up to 120
lM.28 We thus have good reason to believe PCNs also
possess low toxicity because of the similar compositions.
Further, Tween is commonly considered to be more biocom-
patible than Span; for example, Tween 80 is often employed
as additives in clinically used injectable formulations.
CONCLUSION
The promise of developing cationic niosomes as gene deliv-
ery carriers was attractive. Compared with cationic
liposomes, cationic niosomes possess great superiority in
chemical stability and cost-effectiveness. PCNs were only
composed of Tween surfactant and DC-Chol. The cationic
cholesterol, DC-Chol, not only helps with building the nioso-
mal bilayer structure but also offers positive charge to both
bind nucleic acid drugs and facilitate the access to the nega-
tive cellular membrane, and it thereby improves intracellu-
lar transfer (e.g., escape from endosomes). Tween surfac-
tants, owing to their unique structure, play an important
role in PCNs. PCNs showed great advantage on the aspects
of stability and high efficiency of gene transfer as well as
the biocompatibility. Tween 85/DC-Chol niosomes specifi-
cally showed the highest efficiency and the potential to be
developed as a nonviral gene carrier.
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